CATABASIS PHARMACEUTICALS IN - COM NEW Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2018 to Q3 2021

Type / Class
Equity / COM NEW
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM NEW across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2021 Q3 0 $0 -$86,025,192 0
2021 Q2 40,773,220 $86,027,840 +$61,296,240 $2.11 56
2021 Q1 11,072,952 $32,000,737 +$12,950,932 $2.89 59
2020 Q4 6,945,924 $14,866,527 -$19,573,439 $2.14 59
2020 Q3 8,247,497 $51,080,884 +$1,352,180 $6.19 50
2020 Q2 8,005,833 $51,492,347 +$12,947,405 $6.43 49
2020 Q1 6,012,208 $24,921,000 +$1,571,662 $4.15 25
2019 Q4 5,292,741 $31,281,000 +$1,377,333 $5.91 26
2019 Q3 4,422,824 $23,862,000 +$261,670 $5.40 25
2019 Q2 4,355,849 $35,137,000 +$1,605,596 $8.07 23
2019 Q1 4,180,038 $33,103,000 +$16,697,544 $7.92 26
2018 Q4 2,111,276 $9,225,000 +$7,913,999 $4.37 19